Hip & pelvis

The Korean Hip Society (대한고관절학회)
권호 표지
DOI QR코드

DOI QR Code

Prevalence of Venous Thromboembolism after Immediate Screening in Hip Fracture Patients

  • Yoon-Vin Kim (Department of Orthopedic Surgery, College of Medicine, The Catholic University of Korea) ;
  • Joo-Hyoun Song (Department of Orthopedic Surgery, College of Medicine, The Catholic University of Korea) ;
  • Young-Wook Lim (Department of Orthopedic Surgery, College of Medicine, The Catholic University of Korea) ;
  • Woo-Lam Jo (Department of Orthopedic Surgery, College of Medicine, The Catholic University of Korea) ;
  • Seung-Hun Ha (Department of Orthopedic Surgery, College of Medicine, The Catholic University of Korea) ;
  • Kee-Haeng Lee (Department of Orthopedic Surgery, College of Medicine, The Catholic University of Korea)
  • Received : 2023.08.05
  • Accepted : 2023.08.10
  • Published : 2024.03.01
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: Venous thromboembolism (VTE) is a major complication for hip fracture patients, and may exist preoperatively. This study aimed to examine the prevalence of VTE after immediate screening in hip fracture patients. Materials and Methods: Hip fracture patients with an elevated level of D-dimer underwent screening for VTE using computed tomography (CT) angiography. Anticoagulation treatments were administered preoperatively to patients diagnosed with VTE, followed by administration of additional anticoagulation postoperatively. Medical records were reviewed to identify risk factors for preoperative VTE and determine the prognosis of the patients. Results: Among 524 hip fracture patients, 66 patients (12.6%) were diagnosed with VTE, including 42 patients with deep vein thrombosis (DVT), 17 patients with pulmonary thromboembolism (PTE), and 7 patients with both DVT and PTE. Of the patients with VTE, 68.2% were diagnosed within 24 hours of injury, and 33.3% of these patients had PTE. VTE patients showed a tendency toward being overweight (P<0.01) and not on anticoagulant medication (P=0.02) compared to patients without VTE. The risk of VTE was higher for femur shaft fractures (odds ratio [OR] 4.83, 95% confidence interval [CI] 2.18-10.69) and overweight patients (OR 2.12, 95% CI 1.17-3.85), and lower for patients who were previously on anticoagulants (OR 0.36, 95% CI 0.18-0.74). Patients with preoperatively diagnosed VTE were asymptomatic before and after surgery. Conclusion: Clinicians should be aware that VTE may be present within 24 hours of injury, and screening for VTE or prophylactic measures should be considered for high-risk patients.

Keywords

References

  1. Anderson FA Jr, Spencer FA. Risk factors for venous thromboembolism. Circulation. 2003;107(23 Suppl 1):I9-16. 
  2. Sevitt S, Gallagher NG. Prevention of venous thrombosis and pulmonary embolism in injured patients. A trial of anticoagulant prophylaxis with phenindione in middle-aged and elderly patients with fractured necks of femur. Lancet. 1959;2:981-9. https://doi.org/10.1016/s0140-6736(59)91464-3 
  3. Shin WC, Lee SM, Suh KT. Recent updates of the diagnosis and prevention of venous thromboembolism in patients with a hip fracture. Hip Pelvis. 2017;29:159-67. https://doi.org/10.5371/hp.2017.29.3.159 
  4. Nakase J, Toribatake Y, Mouri Y, Seki H, Kitaoka K, Tomita K. Heparin versus danaproid for prevention of venous thromboembolism after hip surgery. J Orthop Surg (Hong Kong). 2009;17:6-9. https://doi.org/10.1177/230949900901700102 
  5. Pedersen AB, Ehrenstein V, Szepligeti SK, Sorensen HT. Excess risk of venous thromboembolism in hip fracture patients and the prognostic impact of comorbidity. Osteoporos Int. 2017;28:3421-30. https://doi.org/10.1007/s00198-017-4213-y 
  6. Kearon C. Natural history of venous thromboembolism. Circulation. 2003;107(23 Suppl 1):I22-30. https://doi.org/10.1161/01.CIR.0000078464.82671.78 
  7. Moser KM, LeMoine JR. Is embolic risk conditioned by location of deep venous thrombosis? Ann Intern Med. 1981;94(4 pt 1):439-44. https://doi.org/10.7326/0003-4819-94-4-439 
  8. Negus D, Pinto DJ. Natural history of postoperative deep-vein thrombosis. Lancet. 1969;2:645. https://doi.org/10.1016/s0140-6736(69)90355-9 
  9. Geerts WH, Code KI, Jay RM, Chen E, Szalai JP. A prospective study of venous thromboembolism after major trauma. N Engl J Med. 1994;331:1601-6. https://doi.org/10.1056/NEJM199412153312401 
  10. Brown CA, Starr AZ, Nunley JA. Analysis of past secular trends of hip fractures and predicted number in the future 2010-2050. J Orthop Trauma. 2012;26:117-22. https://doi.org/10.1097/BOT.0b013e318219c61a 
  11. Schulman S, Ageno W, Konstantinides SV. Venous thromboembolism: past, present and future. Thromb Haemost. 2017;117:1219-29. https://doi.org/10.1160/TH16-10-0823 
  12. Collaborative overview of randomised trials of antiplatelet therapy--III: reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. Antiplatelet Trialists' Collaboration. BMJ. 1994;308:235-46. 
  13. White RH, Romano PS, Zhou H, Rodrigo J, Bargar W. Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty. Arch Intern Med. 1998;158:1525-31. https://doi.org/10.1001/archinte.158.14.1525 
  14. The ICM-VTE Trauma Delegates. Recommendations from the ICM-VTE: trauma. J Bone Joint Surg Am. 2022;104(Suppl 1):280-308. https://doi.org/10.2106/JBJS.21.01476 
  15. Song K, Yao Y, Rong Z, Shen Y, Zheng M, Jiang Q. The preoperative incidence of deep vein thrombosis (DVT) and its correlation with postoperative DVT in patients undergoing elective surgery for femoral neck fractures. Arch Orthop Trauma Surg. 2016;136:1459-64. https://doi.org/10.1007/s00402-016-2535-4 
  16. He SY, Zhang P, Qin HJ, Jiang N, Yu B. Incidence and risk factors of preoperative deep venous thrombosis following hip fracture: a retrospective analysis of 293 consecutive patients. Eur J Trauma Emerg Surg. 2022;48:3141-7. https://doi.org/10.1007/s00068-021-01861-3 
  17. Shin WC, Woo SH, Lee SJ, Lee JS, Kim C, Suh KT. Preoperative prevalence of and risk factors for venous thromboembolism in patients with a hip fracture: an indirect multidetector CT venography study. J Bone Joint Surg Am. 2016;98:2089-95. https://doi.org/10.2106/JBJS.15.01329 
  18. Desciak MC, Martin DE. Perioperative pulmonary embolism: diagnosis and anesthetic management. J Clin Anesth. 2011;23:153-65. https://doi.org/10.1016/j.jclinane.2010.06.011 
  19. Koessler MJ, Fabiani R, Hamer H, Pitto RP. The clinical relevance of embolic events detected by transesophageal echocardiography during cemented total hip arthroplasty: a randomized clinical trial. Anesth Analg. 2001;92:49-55. https://doi.org/10.1097/00000539-200101000-00010 
  20. White RH. The epidemiology of venous thromboembolism. Circulation. 2003;107(23 Suppl 1):I4-8. 
  21. Goldhaber SZ. Risk factors for venous thromboembolism. J Am Coll Cardiol. 2010;56:1-7. https://doi.org/10.1016/j.jacc.2010.01.057 
  22. Kruger PC, Eikelboom JW, Douketis JD, Hankey GJ. Deep vein thrombosis: update on diagnosis and management. Med J Aust. 2019;210:516-24. https://doi.org/10.5694/mja2.50201 
  23. Dalen JE, Alpert JS. Natural history of pulmonary embolism. Prog Cardiovasc Dis. 1975;17:259-70. https://doi.org/10.1016/s0033-0620(75)80017-x 
  24. National Institute for Health and Care Excellence (NICE). Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism [Internet]. London: NICE; 2018 Mar 21 [updated 2019 Aug 13; cited 2022 Sep 8]. Available from: https://www.nice.org.uk/guidance/ng89 
  25. Anderson DR, Morgano GP, Bennett C, et al. American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients. Blood Adv. 2019;3:3898-944. https://doi.org/10.1182/bloodadvances.2019000975 
  26. Falck-Ytter Y, Francis CW, Johanson NA, et al. Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e278S-325S. https://doi.org/10.1378/chest.11-2404 
  27. National Institute for Health and Care Excellence (NICE). Venous thromboembolism in adults [Internet]. London: NICE; 2021 Aug 19 [cited 2022 Sep 8]. Available from: https://www.nice.org.uk/guidance/qs201 
  28. Ley EJ, Brown CVR, Moore EE, et al. Updated guidelines to reduce venous thromboembolism in trauma patients: a Western Trauma Association critical decisions algorithm. J Trauma Acute Care Surg. 2020;89:971-81. https://doi.org/10.1097/TA.0000000000002830
  29. Moon KH, Kang JS, Youn YH. Is the oral chemical prophylaxis necessary for the prevention of venous thromboembolism after joint arthroplasty in a Korean population? Hip Pelvis. 2019;31:150-7. https://doi.org/10.5371/hp.2019.31.3.150 
  30. Anderson DR, Dunbar M, Murnaghan J, et al. Aspirin or rivaroxaban for VTE prophylaxis after hip or knee arthroplasty. N Engl J Med. 2018;378:699-707. https://doi.org/10.1056/NEJMoa1712746 
  31. Flevas DA, Megaloikonomos PD, Dimopoulos L, Mitsiokapa E, Koulouvaris P, Mavrogenis AF. Thromboembolism prophylaxis in orthopaedics: an update. EFORT Open Rev. 2018;3:136-48. https://doi.org/10.1302/2058-5241.3.170018 
  32. Kabrhel C, Mark Courtney D, et al. Factors associated with positive D-dimer results in patients evaluated for pulmonary embolism. Acad Emerg Med. 2010;17:589-97. https://doi.org/10.1111/j.1553-2712.2010.00765.x